Advertisement

The Journal of Physiological Sciences

, Volume 65, Issue 1, pp 99–104 | Cite as

Contributions of purinergic P2X3 receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain

  • Jianfei Guo
  • Xudong FuEmail author
  • Xia Cui
  • Minhua Fan
Original Paper

Abstract

Hyperalgesia and allodynia are commonly observed in patients with diabetic neuropathy. The mechanisms responsible for neuropathic pain are not well understood. Thus, in this study, we examined the role played by purinergic P2X3 receptors of the midbrain periaqueductal gray (PAG) in modulating diabetes-induced neuropathic pain because this brain region is an important component of the descending inhibitory system to control central pain transmission. Our results showed that mechanical withdrawal thresholds were significantly increased by stimulation of P2X3 receptors in the dorsolateral PAG of rats (n = 12, P < 0.05 vs. vehicle control) using α,β-methylene-ATP (α,β-meATP, a P2X3 receptor agonist). In addition, diabetes was induced by an intraperitoneal injection of streptozotocin (STZ) in rats, and mechanical allodynia was observed 3 weeks after STZ administration. Notably, the excitatory effects of P2X3 stimulation on mechanical withdrawal thresholds were significantly blunted in STZ-induced diabetic rats (n = 12, P < 0.05 vs. control animals) as compared with control rats (n = 12). Furthermore, the protein expression of P2X3 receptors in the plasma membrane of the dorsolateral PAG of STZ-treated rats was significantly decreased (n = 10, P < 0.05 vs. control animals) compared to that in control rats (n = 8), whereas the total expression of P2X3 receptors was not significantly altered. Overall, data of our current study suggest that a decrease in the membrane expression of P2X3 receptors in the PAG of diabetic rats is likely to impair the descending inhibitory system in modulating pain transmission and thereby contributes to the development of mechanical allodynia in diabetes.

Keywords

P2X receptor Diabetic neuropathy Midbrain PAG 

Notes

Conflict of interest

None.

References

  1. 1.
    Behbehani MM (1995) Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46:575–605PubMedCrossRefGoogle Scholar
  2. 2.
    Benarroch EE (2012) Periaqueductal gray: an interface for behavioral control. Neurology 78:210–217PubMedCrossRefGoogle Scholar
  3. 3.
    Benbow J, Chan AW, Bowsher D, MacFarlane IA, Williams G (1994) A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med 11:17–21PubMedCrossRefGoogle Scholar
  4. 4.
    Bhatt MP, Lim Y-C, Hwang JY, Na SH, Kim Y-M, Ha K-S (2013) C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation. Diabetes 62:243–253PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Burnstock G (2009) Purinergic receptors and pain. Curr Pharm Des 15:1717–1735PubMedCrossRefGoogle Scholar
  6. 6.
    Carrive P, Morgan MM (2012) Periaqueductal gray. In: Mai JK, Paxinos G (eds) The human nervous system, 3rd edn. Academic Press, San Diego, pp 367–400CrossRefGoogle Scholar
  7. 7.
    Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63PubMedCrossRefGoogle Scholar
  8. 8.
    Cho HJ, Staikopoulos V, Furness JB, Jennings EA (2009) Inflammation induced increase in hyperpolarization-activated, cyclic nucleotide-gated channel protein in trigeminal ganglion neurons and the effect of buprenorphine. Neuroscience 162:453–461PubMedCrossRefGoogle Scholar
  9. 9.
    Gooch C, Podwall D (2004) The diabetic neuropathies. Neurologist 10:311–322PubMedCrossRefGoogle Scholar
  10. 10.
    Klemm WR (2004) Habenular and interpeduncularis nuclei: shared components in multiple-function networks. Med Sci Monit 10:RA261–RA273PubMedGoogle Scholar
  11. 11.
    Migita K, Moriyam T, Koguchi M, Hond K, Katsuragi T, Takano Y, Ueno S (2009) Modulation of P2X receptors in dorsal root ganglion neurons of streptozotocin-induced diabetic neuropathy. Neurosci Lett 452:200–203PubMedCrossRefGoogle Scholar
  12. 12.
    Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355–474PubMedCrossRefGoogle Scholar
  13. 13.
    Morgado C, Terra PP, Tavares I (2010) Neuronal hyperactivity at the spinal cord and periaqueductal grey during painful diabetic neuropathy: effects of gabapentin. Eur J Pain (London, England) 14:693–699CrossRefGoogle Scholar
  14. 14.
    Norenberg W, Illes P (2000) Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch Pharmacol 362:324–339PubMedCrossRefGoogle Scholar
  15. 15.
    North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013–1067PubMedGoogle Scholar
  16. 16.
    Paulson PE, Wiley JW, Morrow TJ (2007) Concurrent activation of the somatosensory forebrain and deactivation of periaqueductal gray associated with diabetes-induced neuropathic pain. Exp Neurol 208:305–313PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Silva M, Amorim D, Almeida A, Tavares I, Pinto-Ribeiro F, Morgado C (2013) Pronociceptive changes in the activity of rostroventromedial medulla (RVM) pain modulatory cells in the streptozotocin-diabetic rat. Brain Res Bull 96:39–44PubMedCrossRefGoogle Scholar
  18. 18.
    Sima AAF, Li Z-G (2005) The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 54:1497–1505PubMedCrossRefGoogle Scholar
  19. 19.
    Spruce MC, Potter J, Coppini DV (2003) The pathogenesis and management of painful diabetic neuropathy: a review. Diabet Med 20:88–98PubMedCrossRefGoogle Scholar
  20. 20.
    Swanson LW (1998) Brain maps: structure of the rat brain. Elsevier, New YorkGoogle Scholar
  21. 21.
    Worthington RA, Arumugam TV, Hansen MA, Balcar VJ, Barden JA (1999) Identification and localisation of ATP P2X receptors in rat midbrain. Electrophoresis 20:2077–2080PubMedCrossRefGoogle Scholar
  22. 22.
    Xiao Z, Ou S, He WJ, Zhao YD, Liu XH, Ruan HZ (2010) Role of midbrain periaqueductal gray P2X3 receptors in electroacupuncture-mediated endogenous pain modulatory systems. Brain Res 1330:31–44PubMedCrossRefGoogle Scholar
  23. 23.
    Xing J, Lu J, Li J (2008) Purinergic P2X receptors presynaptically increase glutamatergic synaptic transmission in dorsolateral periaqueductal gray. Brain Res 1208:46–55PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Xu G-Y, Li G, Liu N, Huang L-Y (2011) Mechanisms underlying purinergic P2X3 receptor mediated mechanical allodynia induced in diabetic rats. Mol Pain 7:60PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Xu GY, Huang LY (2004) Ca2+/calmodulin-dependent protein kinase II potentiates ATP responses by promoting trafficking of P2X receptors. Proc Natl Acad Sci USA 101:11868–11873PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© The Physiological Society of Japan and Springer Japan 2014

Authors and Affiliations

  1. 1.Department of EndocrinologyLiaocheng People’s HospitalLiaochengChina

Personalised recommendations